| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.12 | 3e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-05 |